Skip to main content
Clinical Trials/NCT03604081
NCT03604081
Withdrawn
Not Applicable

Effectiveness of Modified Constraint Induced Movement Therapy to Improve Lower Extremity Function in the Acute and Subacute Stroke Patients by Providing 1 Hour of Intense Massed Practice in the Form of Shaping or Task Practice, 7 Times Per Week for 2 Weeks.

NYU Langone Health1 site in 1 countryJune 11, 2018
ConditionsStroke

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Stroke
Sponsor
NYU Langone Health
Locations
1
Primary Endpoint
Stride length as measured by GAITRite.
Status
Withdrawn
Last Updated
5 years ago

Overview

Brief Summary

This is a prospective randomized control trial of patients with unilateral impairment of the lower extremity after stroke. Patients will be randomized to intervention group and control group. Intervention group will receive one hour of intense massed practice of lower extremity either in the form of shaping or task practice. Control group will receive conventional physical therapy for 1 hour as per current standard of care that follows stroke clinical practice guideline.

Registry
clinicaltrials.gov
Start Date
June 11, 2018
End Date
August 14, 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age 55 or older
  • new ischemic stroke as revealed by CT scan or MRI of a brain or as per updated definition by American heart and American stroke association (Sacco et al., 2013)
  • Manual muscle testing with grad of \> 1+ in hip and knee joint musculature
  • able to walk atleast 10 feet indoors with or without assistance and assistive device.
  • Motivated to participate and some initiation of flexion and extension movement in hip, knee and ankle joints.
  • Ability to follow visual/verbal instructions as assessed by a minimum score of 24/30 points on the minimental state examination
  • Fairly intact sensation

Exclusion Criteria

  • Serious cardiac or pulmonary condition or other medical condition that make it difficult or risky to participate in intensive training
  • Severe joint pain or degenerative disease to the musculoskeletal system of the lower extremity
  • other neurological disease 4) problems with following instructions.

Outcomes

Primary Outcomes

Stride length as measured by GAITRite.

Time Frame: 2 Weeks

GAITrite is considered a gold standard for gait analysis. It consists of a mat with the sensors which are pressure sensitive and when patient ambulates on the mat the system measures parameters like step length, stride length, cycle time and velocity.

velocity as measured by GAITRite

Time Frame: 2 Weeks

GAITrite is considered a gold standard for gait analysis. It consists of a mat with the sensors which are pressure sensitive and when patient ambulates on the mat the system measures parameters like step length, stride length, cycle time and velocity.

Cycle time as measured by GAITRite.

Time Frame: 2 Weeks

GAITrite is considered a gold standard for gait analysis. It consists of a mat with the sensors which are pressure sensitive and when patient ambulates on the mat the system measures parameters like step length, stride length, cycle time and velocity.

step length as measured by GAITRite.

Time Frame: 2 Weeks

GAITrite is considered a gold standard for gait analysis. It consists of a mat with the sensors which are pressure sensitive and when patient ambulates on the mat the system measures parameters like step length, stride length, cycle time and velocity.

Study Sites (1)

Loading locations...

Similar Trials